NCT06746467

Brief Summary

To evaluate the corneal topographic changes in VKC patients using Pentacam and prevalence of KC development in VKC.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for all trials

Timeline
7mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress62%
Jun 2025Dec 2026

First Submitted

Initial submission to the registry

December 16, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 24, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

December 24, 2024

Status Verified

December 1, 2024

Enrollment Period

1.5 years

First QC Date

December 16, 2024

Last Update Submit

December 19, 2024

Conditions

Keywords

corneal topography on vkc

Outcome Measures

Primary Outcomes (1)

  • evaluate the corneal topographic changes in VKC patients using Pentacam

    1 year

Secondary Outcomes (1)

  • prevalence of KC development in VKC

    1 year

Interventions

pentacamDEVICE

evaluate corneal changes by pentacam

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients will be selected from primary clinic

You may qualify if:

  • clinical diagnosis of vernal keratoconjunctivitis -

You may not qualify if:

  • patients with corneal disease as corneal opacity, corneal dystrophy or degenerative changes patients with previous corneal surgery patients with ocular trauma.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut University

Asyut, Egypt

Location

Related Publications (1)

  • Dantas PE, Alves MR, Nishiwaki-Dantas MC. Topographic corneal changes in patients with vernal keratoconjunctivitis. Arq Bras Oftalmol. 2005 Sep-Oct;68(5):593-8. doi: 10.1590/s0004-27492005000500004. Epub 2005 Nov 28.

MeSH Terms

Conditions

Keratoconjunctivitis

Condition Hierarchy (Ancestors)

ConjunctivitisConjunctival DiseasesEye DiseasesKeratitisCorneal Diseases

Central Study Contacts

monica basem fayez, doctor

CONTACT

dalia mohamed mohamed, professer

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecture

Study Record Dates

First Submitted

December 16, 2024

First Posted

December 24, 2024

Study Start

June 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

December 24, 2024

Record last verified: 2024-12

Locations